Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Matthew H. Larson, Wenying Pan, Hyunsung John Kim, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Molecular Biomarkers in Cancer
Virinder Kaur Sarhadi, Gemma Armengol
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1021-1021
Open Access | Times Cited: 296
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Philip J. Johnson, Qing Zhou, Doan Y Dao, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 670-681
Closed Access | Times Cited: 210
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
Antonio Passaro, Maise Al Bakir, Emily G. Hamilton, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1617-1635
Open Access | Times Cited: 150
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening
Daniel C. Chung, Darrell M. Gray, Harminder Singh, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 11, pp. 973-983
Closed Access | Times Cited: 142
Circulating tumor DNA: current challenges for clinical utility
Donna K. Dang, Ben Ho Park
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 120
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
J.E. Berchuck, Francesco Facchinetti, Daniel DiToro, et al.
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1269-1283
Open Access | Times Cited: 86
Future of Digital Assays to Resolve Clinical Heterogeneity of Single Extracellular Vesicles
Renee‐Tyler T. Morales, Jina Ko
ACS Nano (2022) Vol. 16, Iss. 8, pp. 11619-11645
Open Access | Times Cited: 85
The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
Austin K. Mattox, Christopher Douville, Yuxuan Wang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2166-2179
Open Access | Times Cited: 69
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests
Tiago Brito‐Rocha, Vera Constâncio, Rui Henrique, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 935-935
Open Access | Times Cited: 51
Liquid Biopsy Based on Cell-Free DNA and RNA
Conor J. Loy, Lauren S. Ahmann, Iwijn De Vlaminck, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 169-195
Closed Access | Times Cited: 24
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 19
Charting the epitranscriptomic landscape across RNA biotypes using native RNA nanopore sequencing
Gregor Diensthuber, Eva Maria Novoa
Molecular Cell (2025) Vol. 85, Iss. 2, pp. 276-289
Closed Access | Times Cited: 2
Recent progress on transition metal dichalcogenide-based composites for cancer therapy
Bo Chen, Yue Dai, S.‐Y. Yang, et al.
Nanoscale (2025)
Closed Access | Times Cited: 2
Cell types of origin of the cell-free transcriptome
Sevahn K. Vorperian, Mira N. Moufarrej, Robert C. Jones, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 855-861
Open Access | Times Cited: 69
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
Anna-Lisa Doebley, Minjeong Ko, Hanna Liao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 66
RETRACTED ARTICLE: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA
Zengyu Feng, Kexian Li, Kai Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Cancer type classification using plasma cell-free RNAs derived from human and microbes
Shanwen Chen, Yunfan Jin, Siqi Wang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 45
Current challenges and best practices for cell-free long RNA biomarker discovery
L. Cabus, Julien Lagarde, João Curado, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 40
Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
Xiaosha Wen, Huijie Pu, Quan Liu, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6025-6025
Open Access | Times Cited: 40
Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies
Breeshey Roskams-Hieter, Hyun Ji Kim, Pavana Anur, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 39
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006284-e006284
Open Access | Times Cited: 34
Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood
Yuhuan Tao, Shaozhen Xing, Shuai Zuo, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 11, pp. 101281-101281
Open Access | Times Cited: 27
Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer
Arianna Marinello, Marco Tagliamento, Arianna Pagliaro, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102791-102791
Open Access | Times Cited: 9
Breaking the Bone Marrow Barrier: Peripheral Blood as a Gateway to Measurable Residual Disease Detection in Acute Myelogenous Leukemia
John T. Butler, William M. Yashar, Ronan T. Swords
American Journal of Hematology (2025)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top